<DOC>
	<DOCNO>NCT02761538</DOCNO>
	<brief_summary>The investigator develop Aviitam® online platform . The purpose project test medico-economic impact relate utilization Aviitam online platform primary care . Primary objective : To assess cost-effectiveness 24 month follow-up utilization Aviitam® online software primary care people obesity least one comorbidity compare usual follow-up primary care . Secondary objective : Weight loss ; quality life ; blood pressure change ; change lipid profile , blood glucose HbA1c ; physician satisfaction ; patient satisfaction , profile patient data mining analysis collect data . Method : Overweight &amp; obese patient associate comorbidities receive 24 month follow-up assess impact use online platform Aviitam® . Practitioners randomize lot Aviitam® group control group ( usual care ) . A medico-economic analysis conduct cost-effectiveness analysis budget impact analysis . With hypothesis primary endpoint , calculation require number subject base quality life . 150 patient include per group Patients 2 group assess baseline 24 month . The first day month , patient include study receive questionnaire fill online evaluate health care consumption previous month EQ5D questionnaire , standardized questionnaire validate French assess effect health use calculate cost - utility . Expected result perspectives Proving effectiveness Aviitam® online program focus non-drug therapy therapeutic lifestyle change overweight obesity management reduced health cost , improvement quality life , reduction weight improvement comorbidities . In term public health , use platform Aviitam® expect improve management excess body weight reduced health cost . Furthermore , Aviitam® could valuable tool support healthcare professional outpatient therapeutic education approach .</brief_summary>
	<brief_title>Medico-economic Evaluation Obesity</brief_title>
	<detailed_description>Method : Overweight &amp; obese patient associate comorbidities ( hypertension , prediabetes , type 2 diabetes , dyslipidemia , sleep disorder , past history CVDs &gt; 6 month , stable CVD , peripheral arterial disease ) receive 24 month follow-up assess impact use online platform Aviitam® . Practitioners randomize lot Aviitam® group control group ( usual care ) . A medico-economic analysis conduct cost-effectiveness analysis budget impact analysis . With hypothesis primary endpoint , calculation require number subject base quality life . 150 patient include per group , total 300 patient .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<criteria>Man woman age 3565 year Having sign informed write consent Being affiliate social security With BMI 25 45 kg / m2 least one follow criterion associate : A known hypertension treat A know prediabetes [ fast glucose 110 126 mg / l metabolic syndrome define 2009 consensus International Diabetes Federation American heart Association . A known type 2 diabetes , treat A know dyslipidemia treat A known sleep disorder A known history cardiovascular disease &gt; 6 month , stable know cardiovascular disease , peripheral arterial disease . No Having sign informed write consent No Being affiliate social security</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>obesity</keyword>
	<keyword>Overweight</keyword>
	<keyword>ICTs</keyword>
	<keyword>Cost-effectiveness</keyword>
</DOC>